1240565-06-3

Basic information

• Product Name: 1-cyclopropyl-1H-pyrazol-3-amine
• Synonyms: 1-cyclopropyl-1H-pyrazol-3-amine
• CAS NO: 1240565-06-3
• Molecular Formula: C6H9N3
• Molecular Weight: 123.15576
• Mol File: 1240565-06-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 291.8±13.0 °C(Predicted)
• Appearance: /
• Density: 1.46±0.1 g/cm3(Predicted)
• PKA: 5.47±0.12(Predicted)
• CAS DataBase Reference: 1-cyclopropyl-1H-pyrazol-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-cyclopropyl-1H-pyrazol-3-amine(1240565-06-3)
• EPA Substance Registry System: 1-cyclopropyl-1H-pyrazol-3-amine(1240565-06-3)

Safety Data

• Hazardous Substances Data: 1240565-06-3(Hazardous Substances Data)

Usage

General Description

1-cyclopropyl-1H-pyrazol-3-amine, also known as CPPI, is a chemical compound with a molecular formula of C5H7N3. It is a small molecule that contains a cyclopropyl group and a pyrazol-3-amine functional group. CPPI is commonly used in research and pharmaceutical applications due to its diverse biological activities. It has been studied for its potential anti-inflammatory and anti-cancer properties, as well as its ability to inhibit certain enzymes. CPPI may also have applications in the development of new drugs and treatments for various medical conditions. Overall, CPPI is a versatile and important chemical compound with potential therapeutic benefits in the pharmaceutical industry.

Upstream product

• 1262669-27-1 1-cyclopropyl-3-(2,5-dimethyl-1H-pyrrol-1-yl)-1H-pyrazole 

Relevant articles and documents

MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

The present invention relates to macrocyclic compounds, such as macrocyclic sulfonyl ureas. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions and to the use of such compounds in the treatment and

NOVEL COMPOUNDS

The present invention relates to substituted 5-membered nitrogen containing heteroaryl compounds, such as sulfonyl triazoles, where the heteroaryl ring is further substituted, optionally via a linking group such as -NH-, with a cyclic group which in turn is substituted at the α-position. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.

Syntheses of 1-substituted-3-aminopyrazoles

A series of 1-substituted-3-aminopyrazoles were prepared via Chan-Lam coupling reactions, alkylation, and pyrazole ring formation.